CY1118861T1 - Αναγνωριση εξω-κυτταρικης μορφης του ρτεν που μπορει να χρησιμοποιηθει για την θεραπεια ογκων - Google Patents
Αναγνωριση εξω-κυτταρικης μορφης του ρτεν που μπορει να χρησιμοποιηθει για την θεραπεια ογκωνInfo
- Publication number
- CY1118861T1 CY1118861T1 CY20171100268T CY171100268T CY1118861T1 CY 1118861 T1 CY1118861 T1 CY 1118861T1 CY 20171100268 T CY20171100268 T CY 20171100268T CY 171100268 T CY171100268 T CY 171100268T CY 1118861 T1 CY1118861 T1 CY 1118861T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- reten
- determination
- cell form
- external cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Παρέχεται ένα απομονωμένο μακρύ πολυπεπτίδιο ομόλογο ανθρώπινης φωσφατάσης και tensin (ΡΤΕΝ-μακρύ) που περιλαμβάνει SEQ ID ΝΟ:1, θραύσματα και ανάλογα αυτού, νουκλεϊκά (nucleic) οξέα κωδικοποίησης αυτού και συνθέσεις που το περιέχουν. Παρέχονται μέθοδοι καταστολής αγγειογένεσης σε ένα στερεό όγκο, θεραπεία στερεού όγκου, και καταστολή ανάπτυξης ενός στερεού όγκου χρησιμοποιώντας το ΡΤΕΝ-μακρύ, θραύσματα και ανάλογα αυτού.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20797409P | 2009-02-17 | 2009-02-17 | |
PCT/US2010/000469 WO2010096173A2 (en) | 2009-02-17 | 2010-02-17 | Identification of extracellular form of pten that can be used to treat tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118861T1 true CY1118861T1 (el) | 2018-01-10 |
Family
ID=42634379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100268T CY1118861T1 (el) | 2009-02-17 | 2017-02-28 | Αναγνωριση εξω-κυτταρικης μορφης του ρτεν που μπορει να χρησιμοποιηθει για την θεραπεια ογκων |
Country Status (18)
Country | Link |
---|---|
US (1) | US9017981B2 (el) |
EP (1) | EP2400973B1 (el) |
JP (2) | JP5767117B2 (el) |
CN (1) | CN102387810B (el) |
AU (2) | AU2010216370A1 (el) |
BR (1) | BRPI1005951A2 (el) |
CA (1) | CA2752590C (el) |
CY (1) | CY1118861T1 (el) |
DK (1) | DK2400973T3 (el) |
ES (1) | ES2623393T3 (el) |
HR (1) | HRP20170306T1 (el) |
HU (1) | HUE032028T2 (el) |
LT (1) | LT2400973T (el) |
MX (1) | MX2011008695A (el) |
PL (1) | PL2400973T3 (el) |
PT (1) | PT2400973T (el) |
SI (1) | SI2400973T1 (el) |
WO (1) | WO2010096173A2 (el) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3017689A1 (en) * | 2010-02-17 | 2011-08-25 | The Trustees Of Columbia University In The City Of New York | Use of pten-long leader sequence for transmembrane delivery of molecules |
WO2015105957A1 (en) * | 2014-01-08 | 2015-07-16 | Shriners Hospitals For Children | Pten antagonist peptides and methods of using the same |
WO2018023114A1 (en) * | 2016-07-29 | 2018-02-01 | Ohio State Innovation Foundation | Expression of pten-long with ocolytic viruses |
CN109022461B (zh) * | 2017-06-08 | 2022-01-14 | 中山大学附属第一医院 | 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用 |
CN108504671A (zh) * | 2018-03-28 | 2018-09-07 | 宁波市医疗中心李惠利医院 | 一种PTEN-Long蛋白纯化制备方法 |
CN112236131A (zh) | 2018-03-29 | 2021-01-15 | 技术研究及发展基金有限公司 | 包含pten抑制剂的囊泡及其用途 |
CN114127122A (zh) * | 2019-04-12 | 2022-03-01 | 治疗生物科学公司 | 制备磷酸酶与张力蛋白同源物(pten)融合物的组合物和方法 |
CN112813046A (zh) * | 2021-01-08 | 2021-05-18 | 北京大学 | 一种pten亚型蛋白及其应用 |
CN112877309B (zh) * | 2021-02-19 | 2022-05-17 | 北京大学 | 一种N端延长型PTEN亚型PTENζ蛋白及其编码基因和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6482795B1 (en) * | 1997-01-30 | 2002-11-19 | Myriad Genetics, Inc. | Tumor suppressor designated TS10q23.3 |
AU6513701A (en) | 2000-05-30 | 2001-12-11 | Advanced Res & Tech Inst | Compositions and methods for identifying agents which modulate pten function andpi-3 kinase pathways |
US20040266713A1 (en) | 2003-04-23 | 2004-12-30 | Shan Lu | Methods and compositions for solid tumor treatment |
EP2301963A1 (en) * | 2004-09-23 | 2011-03-30 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
CA3017689A1 (en) | 2010-02-17 | 2011-08-25 | The Trustees Of Columbia University In The City Of New York | Use of pten-long leader sequence for transmembrane delivery of molecules |
-
2010
- 2010-02-17 SI SI201031412A patent/SI2400973T1/sl unknown
- 2010-02-17 ES ES10744058.8T patent/ES2623393T3/es active Active
- 2010-02-17 PL PL10744058T patent/PL2400973T3/pl unknown
- 2010-02-17 MX MX2011008695A patent/MX2011008695A/es active IP Right Grant
- 2010-02-17 PT PT107440588T patent/PT2400973T/pt unknown
- 2010-02-17 AU AU2010216370A patent/AU2010216370A1/en not_active Abandoned
- 2010-02-17 CA CA2752590A patent/CA2752590C/en not_active Expired - Fee Related
- 2010-02-17 CN CN201080016333.3A patent/CN102387810B/zh not_active Expired - Fee Related
- 2010-02-17 DK DK10744058.8T patent/DK2400973T3/en active
- 2010-02-17 JP JP2011551062A patent/JP5767117B2/ja not_active Expired - Fee Related
- 2010-02-17 HU HUE10744058A patent/HUE032028T2/en unknown
- 2010-02-17 LT LTEP10744058.8T patent/LT2400973T/lt unknown
- 2010-02-17 EP EP10744058.8A patent/EP2400973B1/en active Active
- 2010-02-17 US US13/201,969 patent/US9017981B2/en not_active Expired - Fee Related
- 2010-02-17 BR BRPI1005951A patent/BRPI1005951A2/pt not_active Application Discontinuation
- 2010-02-17 WO PCT/US2010/000469 patent/WO2010096173A2/en active Application Filing
-
2015
- 2015-06-18 JP JP2015123092A patent/JP5973035B2/ja not_active Expired - Fee Related
-
2016
- 2016-09-21 AU AU2016231517A patent/AU2016231517B2/en not_active Ceased
-
2017
- 2017-02-23 HR HRP20170306TT patent/HRP20170306T1/hr unknown
- 2017-02-28 CY CY20171100268T patent/CY1118861T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK2400973T3 (en) | 2017-03-06 |
CA2752590C (en) | 2017-08-22 |
HUE032028T2 (en) | 2017-08-28 |
BRPI1005951A2 (pt) | 2016-10-11 |
EP2400973A4 (en) | 2013-02-27 |
EP2400973B1 (en) | 2016-11-30 |
JP2012517827A (ja) | 2012-08-09 |
PL2400973T3 (pl) | 2017-09-29 |
JP2015231372A (ja) | 2015-12-24 |
US20120039861A1 (en) | 2012-02-16 |
CN102387810A (zh) | 2012-03-21 |
JP5973035B2 (ja) | 2016-08-17 |
WO2010096173A2 (en) | 2010-08-26 |
AU2016231517A1 (en) | 2016-10-06 |
PT2400973T (pt) | 2017-03-07 |
WO2010096173A3 (en) | 2010-10-21 |
AU2010216370A1 (en) | 2011-09-22 |
ES2623393T3 (es) | 2017-07-11 |
MX2011008695A (es) | 2011-10-14 |
US9017981B2 (en) | 2015-04-28 |
AU2016231517B2 (en) | 2018-01-25 |
SI2400973T1 (sl) | 2017-05-31 |
CN102387810B (zh) | 2017-08-04 |
HRP20170306T1 (hr) | 2017-04-21 |
CA2752590A1 (en) | 2010-08-26 |
JP5767117B2 (ja) | 2015-08-19 |
LT2400973T (lt) | 2017-04-10 |
EP2400973A2 (en) | 2012-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118861T1 (el) | Αναγνωριση εξω-κυτταρικης μορφης του ρτεν που μπορει να χρησιμοποιηθει για την θεραπεια ογκων | |
GEP20135967B (en) | Improved reconstituted surfactant composition containing surfactant protein b (sp-b), and surfactant protein c (sp-c) analogs | |
AR086078A1 (es) | Proteinas de fusion y vacunas de combinacion | |
MX2009000659A (es) | Composiciones de polipeptidos de retrovirus endogeno humano y metodo para su uso. | |
BRPI1010880A2 (pt) | polipeptídeos de hormônio de crescimento e métodos de fazer e usar os mesmos. | |
SG10201907775QA (en) | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen | |
PE20081686A1 (es) | Proteinas de fusion que comprenden un antigeno prame (dage) | |
MX2011008763A (es) | Peptidos foxm1 y vacunas que contienen los mismos. | |
CY1122615T1 (el) | Θεραπεια με βλαστοκυτταρα σε παθολογιες τουενδομητριου | |
WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
EA201991059A1 (ru) | МУТАНТНЫЕ ФРАГМЕНТЫ OspA И СВЯЗАННЫЕ С НИМИ СПОСОБЫ И ПРИМЕНЕНИЕ | |
EP2589658A4 (en) | PARTICLE POLYPEPTIDE OF THE REIC / DKK-3 PROTEIN | |
CY1121734T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ | |
RU2021132734A (ru) | Химерные рецепторы антигена, нацеленные на psca | |
AR128395A2 (es) | Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9 | |
WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
MX2009007261A (es) | Vacuna de peptido foxp3. | |
IN2014CN03922A (el) | ||
EA201390811A1 (ru) | Пептиды tomm34 и содержащие их вакцины | |
MX2011008917A (es) | Peptidos vangl1 y vacunas que incluyen los mismos. | |
EP3556857A3 (en) | Cdc45l peptides and vaccines including the same | |
WO2019059817A9 (en) | VACCINE BASED ON FUSION PROTEIN AND PLASMIDIC DNA | |
MX2023012707A (es) | Anticuerpos de la proteina inmunorreceptora de celulas t con dominios ig e itim (anti-tigit) y metodos de uso de estos. | |
MX2016002556A (es) | Métodos y composiciones para el tratamiento de patologías del tejido de cartílago y disco. | |
TW200801034A (en) | Novel sea lice vaccine |